Table of Contents Table of Contents
Previous Page  747 / 916 Next Page
Information
Show Menu
Previous Page 747 / 916 Next Page
Page Background

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S710–S771

S743

activities in open field test, brain cytokines synthesis and suppres-

sion of immune response were registered inmice with passive type

of behavior. Daily consumption of ethanol solution in mice with

chronic alcohol dependence decreased sharply starting from2 days

of anticonvulsant administration and led to the cessation of ethanol

consumption by the 5 day. After anticonvulsant administration for

10 days behavioral parameters inmicewere comparablewith those

in the control group of healthy animals. It also restored brain

cytokines synthesis and significant stimulated humoral immune

response, estimated by the relative number of antibody-forming

spleen cells.

Conclusion

Behavior and immune changes following chronic

ethanol exposure depended on the behavior status of ani-

mals; administration of the original anticonvulsant meta-chloro-

benzhydryl-urea may correct both immune and behavior disorders

in mice with chronic alcohol dependence, so it has promise in the

treatment of alcoholism.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1371

EV1042

Lymphocytes with Fas-receptors of

readiness to apoptosis in

non-psychotic mental disorders

V. Nikitina

1 ,

, T.P. Vetlugina

1

, O.A. Lobacheva

1

, V.A. Rudnitsky

2

,

M.M. Axenov

2

1

Mental Health Research Institute, Tomsk National Research Medical

Center, Russian Academy of Sciences, Department of

Psychoneuroimmunology and Neurobiology, Tomsk, Russia

2

Mental Health Research Institute, Tomsk National Research Medical

Center, Russian Academy of Sciences, Borderline States Department,

Tomsk, Russia

Corresponding author.

Introduction

Apoptosis is a complex physiological process of the

organismwhich supports cellular homeostasis, provides important

aspects of development and functioning of the immune system.

In various pathological conditions the process of apoptosis can be

impaired that leads to decrease or increase in pro-apoptotic activ-

ity.

Materials and methods

We conducted investigation of relative

and absolute number of CD3

+

CD95

+

–lymphocytes in groups of

patients with adjustment disorders (

n

= 90), PTSD (

n

= 100), organic

emotionally labile (asthenic) disorder (

n

= 232), organic personal-

ity disorder (

n

= 93). Clinical verification was conducted according

to ICD–10. Control group included 190 practically healthy persons.

Fas protein (CD95) expression on CD3 lymphocytes surfaces was

detected using flow cytometry. Cytometric measurements were

conducted on flow cytofluorimeter FacsCalibur (Becton Dickinson,

US).

Results

In the control group relative number of CD95

+

lymphocytes was 11.6%, absolute–0.21

×

10

9

/L. In all exam-

ined patients as compared with control the reliable increase

both in relative and absolute number of lymphocytes of

CD3

+

CD95

+

–phenotype was identified. So, in persons with

adjustment disorder content of this indicator made 17.0%

and 0.28

×

10

9

/L (

Р

= 0.0015), in PTSD–18.0% and 0.33

×

10

9

/L

(

Р

= 0.0007) and in patients with organic asthenic disorder–19.0%

and 0.32

×

10

9

/L (

Р

= 0.0048), respectively. The highest content

in blood of CD3

+

–lymphocytes, expressing on the surface of

membrane the basic marker of apoptosis CD95 is observed in

patients with organic personality disorder: 26.0% and 0.44

×

10

9

/L

(

Р

= 0.0003).

Conclusion

In case of intensification of psychopathological symp-

toms especially in persons with non-psychotic organic mental

disorders a receptor-mediated signaling pathway of apoptosis is

activated – process of programmed cell death.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1372

EV1043

Inflammatory markers in mild

cognitive impairment and anxiety

disorders in middle-aged subjects

with metabolic syndrome

V. Piotrovskaya

, N. Neznanov

First State Pavlov Medical University, Psychiatry, St. Petersburg,

Russia

Corresponding author.

Anxiety disorders are increasingly being associated with metabolic

and cardiovascular burden, in contrast with depression; the role

of inflammation in anxiety has sparsely been discussed. A num-

ber of reports of elevated inflammatory markers in mild cognitive

impairment (MCI) suggest that inflammation may be a potential

early marker of the pathological cascade associated with dementia.

The aimof this studywas to evaluate a possible association between

peripheral blood concentrations of inflammatory factors in patients

with MCI and mental processes such as, cognitive impairment and

anxiety in obesity.

Methods and results

The data collected from 271 patients with

MetS according IDF criteria, (aged 30–60 years) have been analyzed.

Lifetime diagnoses of depression (D), anxiety (A) was self-reported.

Current D and A were confirmed by psychodiagnostic interview

according to the criteria of ICD-10. All patients passed through:

MMSE test, Wechsler memory scale, symbol coding and category

Fluency test, scales HADS, HAM-A. Inflammatory markers included

CRP, IL-6, IL-1 and TNF- . Subjects were divided into group A–with

D and/or A (139) and group B–without affective disorders (132).

Using Mann–Whitney test significant connection between pres-

ence of MCI and high levels of inflammation is associated with

simultaneous presence affective disorders. High correlations in

subjects with A/D were between IL-6, IL-1 and MCI. In-group B,

there was no significant correlations between inflammatory mark-

ers and MCI.

Conclusion

There is link between affective disorders and levels

of inflammatory markers. Increased levels of IL-6 and IL-1 provoke

co-morbidity of MCI and depression or anxiety.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1373

EV1044

Autoimmune limbic encephalitis:

When psychiatric symptoms are not

what they seem

A. Samico

, Â. Venâncio

Vila Nova de Gaia Hospitalar Center, Psychiatry and Mental Health

Service, Vila Nova de Gaia, Portugal

Corresponding author.

Introduction

The autoimmune (AI) limbic encephalitis (LE) can

manifests as changes in neuropsychiatric functions and can even

occur with isolated psychiatric symptoms. Many times it is a man-

ifestation of paraneoplastic syndromes and it is lately diagnosed.

Objectives

Our objective is to increase awareness to this pathol-

ogy, since initial contact with these patients is often performed by a

psychiatrist and its early detection and treatment greatly improve

the prognosis of the patients.

Aims

The aim of this presentation is to address the AI LE as a

differential diagnosis in patients with psychiatric symptoms.

Methods

Presentation of a clinical case of AI LE and syndrome

revision.